Peter A. Sloane

1.0k total citations
13 papers, 775 citations indexed

About

Peter A. Sloane is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and Surgery. According to data from OpenAlex, Peter A. Sloane has authored 13 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 2 papers in Emergency Medical Services and 1 paper in Surgery. Recurrent topics in Peter A. Sloane's work include Cystic Fibrosis Research Advances (8 papers), Neonatal Respiratory Health Research (6 papers) and Blood properties and coagulation (1 paper). Peter A. Sloane is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Neonatal Respiratory Health Research (6 papers) and Blood properties and coagulation (1 paper). Peter A. Sloane collaborates with scholars based in United States, Switzerland and Italy. Peter A. Sloane's co-authors include Steven M. Rowe, Li Tang, S. Vamsee Raju, Marina Mazur, Mark T. Dransfield, Clifford Courville, Simon Roche, John P. McCabe, Suresh Shastry and Eric J. Sorscher and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Peter A. Sloane

11 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter A. Sloane United States	11	522	146	120	104	86	13	775
R.K. Knight United Kingdom	15	298 0.6×	120 0.8×	120 1.0×	32 0.3×	96 1.1×	33	650
Alberto Cánepa Italy	13	107 0.2×	69 0.5×	65 0.5×	46 0.4×	76 0.9×	22	508
Eef D. Telenga Netherlands	14	357 0.7×	313 2.1×	107 0.9×	17 0.2×	82 1.0×	18	625
Linda T. Wang United States	7	809 1.5×	76 0.5×	97 0.8×	13 0.1×	120 1.4×	14	1.0k
Masashi Ohe Japan	12	148 0.3×	151 1.0×	62 0.5×	30 0.3×	88 1.0×	50	482
Yılmaz Tabel Türkiye	13	154 0.3×	51 0.3×	95 0.8×	15 0.1×	45 0.5×	49	499
Akihiko Taniguchi Japan	14	303 0.6×	176 1.2×	98 0.8×	9 0.1×	50 0.6×	45	541
V. Polychronopoulos Greece	14	778 1.5×	358 2.5×	109 0.9×	8 0.1×	51 0.6×	19	988
Fernando Diaz del Valle United States	8	220 0.4×	69 0.5×	112 0.9×	9 0.1×	55 0.6×	10	567
Angelantonio Maglio Italy	15	230 0.4×	298 2.0×	85 0.7×	11 0.1×	86 1.0×	38	682

Countries citing papers authored by Peter A. Sloane

Since Specialization

Citations

This map shows the geographic impact of Peter A. Sloane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Sloane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Sloane more than expected).

Fields of papers citing papers by Peter A. Sloane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Sloane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Sloane. The network helps show where Peter A. Sloane may publish in the future.

Co-authorship network of co-authors of Peter A. Sloane

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Sloane. A scholar is included among the top collaborators of Peter A. Sloane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Sloane. Peter A. Sloane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Murphy, Robert, Andrew W. Murphy, Suzanne McDermott, et al.. (2025). Risk-based screening for the evaluation of atrial fibrillation in general practice (R-BEAT): a randomized cross-over trial. QJM. 118(3). 166–173.

Raju, S. Vamsee, et al.. (2017). Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice. Respiratory Research. 18(1). 173–173. 38 indexed citations

White, Marjorie Lee, et al.. (2017). Comparison of recidivism rates for a teenage trauma prevention program after the addition of high-fidelity patient simulation. Traffic Injury Prevention. 19(3). 225–229. 1 indexed citations

Raju, S. Vamsee, Vivian Lin, Carmel M. McNicholas, et al.. (2016). The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke. American Journal of Respiratory Cell and Molecular Biology. 56(1). 99–108. 78 indexed citations

Birket, Susan E., Kengyeh K. Chu, Grace H. Houser, et al.. (2016). Combination therapy with cystic fibrosis transmembrane conductance regulator modulators augment the airway functional microanatomy. American Journal of Physiology-Lung Cellular and Molecular Physiology. 310(10). L928–L939. 50 indexed citations

Sloane, Peter A., et al.. (2016). Pediatric anaphylaxis in the operating room for anesthesia residents: a simulation study. Pediatric Anesthesia. 27(2). 205–210. 11 indexed citations

Raju, S. Vamsee, Patricia L. Jackson, Clifford Courville, et al.. (2013). Cigarette Smoke Induces Systemic Defects in Cystic Fibrosis Transmembrane Conductance Regulator Function. American Journal of Respiratory and Critical Care Medicine. 188(11). 1321–1330. 147 indexed citations

Sloane, Peter A., Suresh Shastry, Andrew M. Wilhelm, et al.. (2012). A Pharmacologic Approach to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Smoking Related Lung Disease. PLoS ONE. 7(6). e39809–e39809. 143 indexed citations

Rowe, Steven M., Peter A. Sloane, Li Tang, et al.. (2011). Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54. Journal of Molecular Medicine. 89(11). 1149–1161. 59 indexed citations

10.

Barsam, Sarah, Bethan Psaila, Marc Forestier, et al.. (2011). Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 117(21). 5723–5732. 119 indexed citations

11.

Sloane, Peter A. & Steven M. Rowe. (2010). Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis. Current Opinion in Pulmonary Medicine. 16(6). 591–597. 53 indexed citations

12.

Pyle, Louise C., Jennifer C. Fulton, Peter A. Sloane, et al.. (2009). Activation of the Cystic Fibrosis Transmembrane Conductance Regulator by the Flavonoid Quercetin. American Journal of Respiratory Cell and Molecular Biology. 43(5). 607–616. 33 indexed citations

13.

Roche, Simon, Peter A. Sloane, & John P. McCabe. (2008). Epidemiology of spine trauma in an Irish regional trauma unit: A 4-year study. Injury. 39(4). 436–442. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact